Global GABA (aminobutyric acid) Market Size By Type (Type I, Type II), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global GABA (Gamma-Aminobutyric Acid) Market was valued at USD 310 million in 2023 and is expected to surpass USD 518 million by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. The market is witnessing robust growth owing to rising consumer demand for natural supplements supporting mental well-being, stress management, and sleep regulation. As GABA is a key inhibitory neurotransmitter in the human brain, its use is expanding in functional foods, nutraceuticals, pharmaceuticals, and dietary supplements, making it an increasingly attractive compound in the health and wellness industry.

Drivers:

1. Growing Demand for Natural Mental Health Supplements:

With heightened awareness around mental health and increasing cases of anxiety and sleep disorders, consumers are actively seeking natural remedies. GABA, being naturally occurring in the human body, has gained popularity as a safe and effective option for calming the nervous system and improving sleep.

2. Expansion of Functional Food & Beverage Sector:

Food and beverage manufacturers are incorporating GABA into products such as teas, energy drinks, and dairy beverages to promote relaxation and stress relief. The functional food trend, especially in Asia-Pacific and North America, is boosting demand.

3. Rising Geriatric Population:

Aging populations across developed economies are more prone to sleep disorders and neurological concerns, increasing the demand for neuroprotective and calming agents like GABA.

Restraints:

1. Regulatory and Labeling Challenges:

GABA is subject to different regulatory frameworks globally. In some countries, it is not approved as a food additive or supplement, limiting its market penetration.

2. Limited Consumer Awareness in Emerging Markets:

Despite growing health trends, the penetration of GABA-based products remains low in several developing regions due to lack of consumer education regarding its benefits.

Opportunity:

1. Growth in Personalized Nutrition & Biohacking:

The rise of personalized health and wellness regimes, including biohacking and nootropics, presents new opportunities for GABA inclusion in smart supplements and precision nutrition platforms.

2. Technological Advancements in Fermentation and Extraction:

Innovations in microbial fermentation and biosynthesis are enabling cost-effective and scalable production of GABA, improving product affordability and availability for manufacturers.

Market by System Type Insights:

Based on system type, the Synthetic GABA segment dominated the market in 2023. Produced primarily via microbial fermentation, synthetic GABA offers high purity, safety, and consistency—essential attributes for pharmaceutical and food-grade applications. However, the Natural GABA segment is projected to grow rapidly due to increased consumer preference for plant-based and clean-label products.

Market by End-use Insights:

In terms of end-use, the Dietary Supplements segment led the global market, accounting for the largest share in 2023. Consumers are increasingly turning to supplements to manage stress, improve focus, and enhance sleep quality. The Pharmaceutical segment is also expected to witness significant growth, particularly with expanding research on GABA’s role in epilepsy, anxiety, and neurodegenerative disorders.

Market by Regional Insights:

Asia-Pacific held the largest share in 2023, driven by the presence of major nutraceutical manufacturers, strong consumer acceptance of functional ingredients, and regulatory support in countries like Japan and South Korea. North America is expected to witness substantial growth owing to increasing mental health concerns, growing demand for non-prescription solutions, and rising adoption of dietary supplements.

Competitive Scenario:

Prominent companies in the Global GABA Market include Pharma Foods International Co., Ltd., Kyowa Hakko Bio Co., Ltd., Evonik Industries AG, Taisho Pharmaceutical Co., Ltd., Nutra Green Biotechnology Co., Ltd., and Zhejiang Yiwan Bio-Tech Co., Ltd. These players are actively engaged in expanding their product portfolios, forming strategic partnerships, and investing in research to enhance product efficacy and regulatory compliance.

Scope of Work – Global GABA (Gamma-Aminobutyric Acid) Market

Key Market Developments:

2023: Kyowa Hakko Bio announced the expansion of its GABA production facilities to meet rising global demand for its patented fermentation-derived GABA used in food and supplements.

2024: Pharma Foods International launched a new line of GABA-infused relaxation drinks in collaboration with a leading beverage manufacturer in Japan.

2025: Nutra Green Biotechnology partnered with distributors in Latin America to increase GABA supplement penetration in the region.

FAQs:

1) What is the current market size of the Global GABA (Gamma-Aminobutyric Acid) Market?

The market size in 2023 was valued at USD 310 million.

2) What is the major growth driver of the Global GABA Market?

The major driver is the growing consumer demand for natural mental health and sleep-support supplements.

3) Which is the largest region during the forecast period in the Global GABA Market?

Asia-Pacific is expected to dominate due to strong functional food culture and favorable regulatory frameworks.

4) Which segment accounted for the largest market share in the Global GABA Market?

The Dietary Supplements segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global GABA Market?

Key players include Pharma Foods International, Kyowa Hakko Bio, Evonik Industries, Taisho Pharmaceutical, and Nutra Green Biotechnology.

Let me know if you want this turned into a downloadable Word document.